Psychiatric Times Covers the Promising Future of Psychedelic-Assisted Therapy

The Psychiatric Times, a monthly medical trade association publication distributed to about 50,000 psychiatrists, posted a testimonial from Dr. Devon Christie, who is helping lead a important psychedelic therapy studies. A licensed therapist and family physician, Dr. Christie specializes in pain management and mental health. Operating out of Vancouver, British Columbia, Canada, she is the director for Numinous Wellness that is seeking to provide evidence-based psychedelic therapies for a variety of conditions such as depression, PTSD, and addiction issues. As the Psychiatric Times notes:

“A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.

“Posttraumatic stress disorder (PTSD) can be exceptionally difficult to treat. But recent studies have suggested the efficacy of a surprising option: mind-altering drugs, in combination with psychotherapy.

“For PTSD, 3,4-methyl​enedioxy​methamphetamine (MDMA) appears to be especially effective.”

In a Mental Health Minute, Devon Christie laid out the latest developments in the field and what might be in the future for psychedelic-assisted psychotherapy. The first study, Dr. Christie discussed was a trial of 20 Canadians utilizing MDMA to combat PTSD. She also discussed a psilocybin-assisted pilot project that “utilizes motivational enhancement therapy for polysubstance use disorder.” And finally, she previewed a safety and feasibility study for a standardized psilocybin extraction from lab-cultivated mushrooms.

With an ongoing global mental health crisis, it is great to see psychedelics garnering more and more mainstream attention. Too many people are suffering when they don’t have to. It’s notable that the Psychiatric Times trade publication is shining a light on these new developments as the mainstream establishment doesn’t always warm up to new ideas that shake up the status quo. It’s very telling that one of the few opponents of the Measure 109 psilocybin initiative was the Oregon Psychiatric Physicians Association. I remember when the Oregon Medical Association and Oregon Nurses Association were big opponents of medicinal cannabis as well, but then ONA actually endorsed the Measure 110 drug decriminalization initiative, demonstrating that change can occur with new evidence and an open mind.

Kind Leaf is happy to help Oregonians feel better and enhance all of the fun trips folks take during the summertime and all seasons. Swing by Pendleton’s premier craft cannabis boutique to see the best selection in the Great Northwest or you can even order online via Leafly. As always, discounts are available for military veterans, senior citizens, and Oregon Medical Marijuana Program (OMMP) patients.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s